Selectis Health annual ebitda
2011
2012
2013
2019
2020
2021
2022
2023
2024
2025
Selectis Health EBITDA Growth & History (GBCS)
Selectis Health's calculated EBITDA was −$90,254 for fiscal 2025.
View full Selectis Health company overviewSelectis Health annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$90,254 | $1.1M | — |
| 2024 | 2024-12-31 | −$1.2M | $6.1M | — |
| 2023 | 2023-12-31 | −$7.3M | −$8.8M | — |
| 2022 | 2022-12-31 | $1.5M | $501,911 | +49.97% |
| 2021 | 2021-12-31 | $1.0M | −$4.0M | −79.73% |
| 2020 | 2020-12-31 | $5.0M | $2.3M | +86.82% |
| 2019 | 2019-12-31 | $2.7M | $1.9M | +275.32% |
| 2013 | 2013-06-30 | $706,709 | $196,888 | +38.62% |
| 2012 | 2012-06-30 | $509,821 | $1.3M | — |
| 2011 | 2011-06-30 | −$837,997 | — | — |
Selectis Health quarterly ebitda
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q4.11
Q1.12
Q4.13
Q1.14
Q3.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q1.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | −$929,282 | −$131,637 | — |
| Q2 2025 | 2025-06-30 | −$87,547 | $266,835 | — |
| Q1 2025 | 2025-03-31 | −$58,726 | $213,939 | — |
| Q4 2024 | 2024-12-31 | $265,464 | $2.8M | — |
| Q3 2024 | 2024-09-30 | −$797,645 | $1.3M | — |
| Q2 2024 | 2024-06-30 | −$354,382 | $789,849 | — |
| Q1 2024 | 2024-03-31 | −$272,665 | $1.3M | — |
| Q4 2023 | 2023-12-31 | −$2.6M | −$1.1M | — |
| Q3 2023 | 2023-09-30 | −$2.1M | −$2.2M | — |
| Q2 2023 | 2023-06-30 | −$1.1M | −$2.9M | — |
| Q1 2023 | 2023-03-31 | −$1.5M | −$2.6M | — |
| Q4 2022 | 2022-12-31 | −$1.5M | −$742,391 | — |
| Q3 2022 | 2022-09-30 | $131,327 | −$1.0M | −88.79% |
| Q2 2022 | 2022-06-30 | $1.8M | $1.3M | +291.11% |
| Q1 2022 | 2022-03-31 | $1.1M | $967,971 | +1011.97% |
| Q4 2021 | 2021-12-31 | −$715,292 | −$1.3M | — |
| Q3 2021 | 2021-09-30 | $1.2M | −$222,059 | −15.93% |
| Q2 2021 | 2021-06-30 | $452,306 | −$1.6M | −77.75% |
| Q1 2021 | 2021-03-31 | $95,652 | −$859,643 | −89.99% |
| Q4 2020 | 2020-12-31 | $573,699 | −$384,622 | −40.13% |
| Q3 2020 | 2020-09-30 | $1.4M | $1.3M | +1148.35% |
| Q2 2020 | 2020-06-30 | $2.0M | $1.6M | +336.87% |
| Q1 2020 | 2020-03-31 | $955,295 | $865,422 | +962.94% |
| Q3 2019 | 2019-09-30 | $958,321 | $993,090 | — |
| Q1 2014 · Sep 30 | 2013-09-30 | $111,647 | −$74,717 | −40.09% |
| Q4 2013 | 2013-06-30 | $465,241 | −$126,563 | −21.39% |
| Q1 2012 · Mar 31 | 2013-03-31 | $89,873 | −$8,235 | −8.39% |
| Q4 2011 | 2012-12-31 | −$34,769 | $182,924 | — |
| Q1 2013 | 2012-09-30 | $186,364 | $148,762 | +395.62% |
| Q4 2012 | 2012-06-30 | $591,804 | $1.6M | — |
| Q3 2012 | 2012-03-31 | $98,108 | $54,105 | +122.96% |
| Q2 2012 | 2011-12-31 | −$217,693 | −$292,350 | — |
| Q1 2012 · Sep 30 | 2011-09-30 | $37,602 | −$44,154 | −54.01% |
| Q4 2011 | 2011-06-30 | −$1.0M | — | — |
| Q3 2011 | 2011-03-31 | $44,003 | — | — |
| Q2 2011 | 2010-12-31 | $74,657 | — | — |
| Q1 2011 | 2010-09-30 | $81,756 | — | — |
Selectis Health ebitda trends
Over the last five reported fiscal years, Selectis Health's ebitda decreased from $5.0M to −$90,254, a change of −$5.0M. The latest reported quarter, Q1 2026, shows −$929,282.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Selectis Health filings at SEC.gov ↗